It is a dubious disease in the field of genetic metabolism, clinical manifestations are complex and often involve multi-systematic stress. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of the disease needs to be combined with a comprehensive assessment of clinical manifestations, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching national and international teams of authoritative experts to provide accurate diagnoses and treatment regimens. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, significant improvements have been made in many previously difficult-to-treat genetic metabolic disorders. Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to changes in disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of urea type III. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.